Blood Biomarkers From Ethnically Diverse Cardiovascular Patients

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The Investigators will create a clinical database and a Biobank of stem cells derived from the blood of participants with cardiovascular disease. The Investigators will recruit participants from diverse racial and ethnic backgrounds with equal representation from both sexes. The Investigators expect to create stem cells and analyze the blood for protein biomarkers and genetic causes of cardiovascular disease. The stem cell biobank and clinical data will be a powerful tool for studying cardiovascular disease.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: t
View:

• Adult (18 to 80 years of age)

• Cardiovascular Disease (CVD)

• Cerebrovascular Disease (CBD)

• Peripheral Vascular Disease (PVD)

• Inherited Arrhythmias

• Cardiomyopathies

• Congenital Heart Disease (CHD)

• Aortopathy

• Hypertension

• Cardiometabolic Disease (CMD)

Locations
Other Locations
Canada
London Regional Health Science Centre
RECRUITING
London
Time Frame
Start Date: 2024-05-01
Estimated Completion Date: 2033-06-30
Participants
Target number of participants: 200
Treatments
study controls
Healthy control participants (n=50) aged 80 and older enrolled in the study with no known CVD or history of significant medical problems.
cardiovascular disease
Participants with cardiovascular disease (n=150)
Related Therapeutic Areas
Sponsors
Collaborators: Greenstone Biosciences, Inc.
Leads: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

This content was sourced from clinicaltrials.gov